← All Syndax Pharmaceuticals INC filings

Syndax Pharmaceuticals INC DEF 14A proxy statements

Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.

NASDAQ
SNDX
Syndax Pharmaceuticals INC
DEF: Syndax Pharmaceuticals 2026 Proxy Statement
Syndax Pharmaceuticals announces its 2026 Annual Meeting of Stockholders to be held virtually on June 10, 2026.
NASDAQ
SNDX
Syndax Pharmaceuticals INC
DEFA14A: Syndax Pharmaceuticals Files Definitive Proxy Statement
Syndax Pharmaceuticals has filed a definitive proxy statement with the SEC.
NASDAQ
SNDX
Syndax Pharmaceuticals INC
DEF: Syndax Pharmaceuticals Sets Date for 2025 Annual Stockholders Meeting, Outlines Key Proposals
Syndax Pharmaceuticals announces its 2025 Annual Meeting of Stockholders to be held virtually on May 14, 2025, featuring proposals for director elections, executive compensation, and auditor ratification.
NASDAQ
SNDX
Syndax Pharmaceuticals INC
DEFA14A: Syndax Pharmaceuticals Files Definitive Proxy Statement with SEC
Syndax Pharmaceuticals has filed a definitive proxy statement with the Securities and Exchange Commission.
NASDAQ
SNDX
Syndax Pharmaceuticals INC
DEF 14A: Syndax Pharmaceuticals Sets Date for 2024 Annual Stockholders Meeting
Syndax Pharmaceuticals will hold its 2024 Annual Meeting of Stockholders virtually on May 15, 2024, to elect directors, vote on executive compensation, and ratify the appointment of its independent accounting firm.